0
0
0
Increasing Medication Access for Seniors Act of 2024
12/19/2024, 9:06 AM
Summary of Bill HR 8725
Bill 118 hr 8725, also known as the Increasing Medication Access for Seniors Act of 2024, aims to improve access to affordable prescription medications for senior citizens in the United States. The bill was introduced in the House of Representatives in response to concerns about rising drug prices and the financial burden this places on older Americans.
The key provisions of the bill include:
1. Allowing Medicare to negotiate drug prices with pharmaceutical companies: Currently, Medicare is prohibited from negotiating directly with drug manufacturers for lower prices. This bill would change that, allowing Medicare to use its purchasing power to negotiate better deals for prescription medications. 2. Expanding access to generic drugs: The bill includes measures to encourage the development and availability of generic versions of brand-name drugs. This would help lower costs for seniors by providing more affordable alternatives to expensive brand-name medications. 3. Increasing transparency in drug pricing: The bill requires pharmaceutical companies to disclose information about the costs of producing and marketing their drugs. This transparency would help identify instances of price gouging and hold drug manufacturers accountable for their pricing practices. 4. Providing financial assistance for low-income seniors: The bill includes provisions to help low-income seniors afford their medications, such as expanding eligibility for Medicare's Extra Help program and increasing funding for prescription drug assistance programs. Overall, the Increasing Medication Access for Seniors Act of 2024 aims to address the challenges that many seniors face in accessing affordable prescription medications. By allowing Medicare to negotiate drug prices, expanding access to generic drugs, increasing transparency in drug pricing, and providing financial assistance for low-income seniors, the bill seeks to make prescription medications more affordable and accessible for older Americans.
The key provisions of the bill include:
1. Allowing Medicare to negotiate drug prices with pharmaceutical companies: Currently, Medicare is prohibited from negotiating directly with drug manufacturers for lower prices. This bill would change that, allowing Medicare to use its purchasing power to negotiate better deals for prescription medications. 2. Expanding access to generic drugs: The bill includes measures to encourage the development and availability of generic versions of brand-name drugs. This would help lower costs for seniors by providing more affordable alternatives to expensive brand-name medications. 3. Increasing transparency in drug pricing: The bill requires pharmaceutical companies to disclose information about the costs of producing and marketing their drugs. This transparency would help identify instances of price gouging and hold drug manufacturers accountable for their pricing practices. 4. Providing financial assistance for low-income seniors: The bill includes provisions to help low-income seniors afford their medications, such as expanding eligibility for Medicare's Extra Help program and increasing funding for prescription drug assistance programs. Overall, the Increasing Medication Access for Seniors Act of 2024 aims to address the challenges that many seniors face in accessing affordable prescription medications. By allowing Medicare to negotiate drug prices, expanding access to generic drugs, increasing transparency in drug pricing, and providing financial assistance for low-income seniors, the bill seeks to make prescription medications more affordable and accessible for older Americans.
Current Status of Bill HR 8725
Bill HR 8725 is currently in the status of Bill Introduced since June 13, 2024. Bill HR 8725 was introduced during Congress 118 and was introduced to the House on June 13, 2024. Bill HR 8725's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024
Bipartisan Support of Bill HR 8725
Total Number of Sponsors
2Democrat Sponsors
2Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
0Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 8725
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 8725
To require the Secretary of Health and Human Services to submit to Congress a report on the option to elect to pay cost-sharing under a prescription drug plan or MA-PD plan in monthly capped amounts.
To require the Secretary of Health and Human Services to submit to Congress a report on the option to elect to pay cost-sharing under a prescription drug plan or MA-PD plan in monthly capped amounts.
Comments
Sponsors and Cosponsors of HR 8725
Latest Bills
Southern Nevada Economic Development and Conservation Act
Bill S 1005December 10, 2025
ADS for Mental Health Services Act
Bill S 414December 10, 2025
ASCEND Act
Bill S 1437December 10, 2025
Reliable Federal infrastructure Act
Bill HR 4690December 10, 2025
SHOWER Act
Bill HR 4593December 10, 2025
Dismissing the election contest relating to the office of Representative from the Fourteenth Congressional District of Florida.
Bill HRES 312December 10, 2025
Dismissing the election contest relating to the office of Representative from the Thirtieth Congressional District of Texas.
Bill HRES 311December 10, 2025
Dismissing the election contest relating to the office of Representative from the at-large Congressional District of Alaska.
Bill HRES 310December 10, 2025
Dismissing the election contest relating to the office of Representative from the Twenty-eighth Congressional District of Texas.
Bill HRES 309December 10, 2025
Dismissing the election contest relating to the office of Representative from the Fourteenth Congressional District of Florida.
Bill HRES 308December 10, 2025


